Who owns Eiger Biopharmaceuticals?
- CUSIP Number: 28249u105
Tip: Access positions for across all investors
Analyze quarterly positions in Eiger Biopharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Eiger Biopharmaceuticals stock
Who bought or sold Eiger Biopharmaceuticals this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Propel Bio Management | 4.4M | $986k | 100% | Dec 2023 |
|
| 683 Capital Management | 2.1M | $472k | -21% | Dec 2023 |
|
| Vanguard Group | 1.8M | $409k | -7% | Dec 2023 |
|
| Millennium Management | 81k | $18k | -70% | Dec 2023 |
|
| Sequoia Financial Advisors | 63k | $14k | 0% | Dec 2023 |
|
| Two Sigma Securities | 57k | $13k | 60% | Dec 2023 |
|
| Bank of America Corporation | 48k | $11k | -4% | Dec 2023 |
|
| Tocqueville Asset Management | 37k | $8.4k | -27% | Dec 2023 |
|
| Charles Schwab Investment Management | 33k | $7.5k | 0% | Dec 2023 |
|
| Townsquare Capital | 32k | $7.3k | 0% | Dec 2023 |
|
| Dfpg Investments | 32k | $8.0k | 0% | Dec 2023 |
|
| Jane Street | 30k | $6.6k | 100% | Dec 2023 |
|
| Hrt Financial | 29k | $6.0k | 100% | Dec 2023 |
|
| Bank of New York Mellon | 21k | $4.6k | 0% | Dec 2023 |
|
| Citadel Advisors | 14k | $3.2k | 100% | Dec 2023 |
|
| Simplex Trading | 13k | $2.0k | 7% | Dec 2023 |
|
| UBS Group | 11k | $2.2k | 19277% | Dec 2023 |
|
| Advisor Group Holdings | 7.8k | $1.7k | -65% | Dec 2023 |
|
| Citigroup | 2.9k | $535.219200 | -21% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 2.9k | $651.948000 | -1% | Dec 2023 |
|
| Rhumbline Advisers | 2.3k | $522.000000 | 0% | Dec 2023 |
|
| Royal Bank of Canada | 1.4k | $0 | 45% | Dec 2023 |
|
| National Bank Of Canada /fi/ | 1.3k | $301.056000 | 0% | Dec 2023 |
|
| Cutler | 1.0k | $0 | 0% | Dec 2023 |
|
| Wells Fargo & Company | 307.00 | $69.351300 | -98% | Dec 2023 |
|
| Jpmorgan Chase & Co | 166.00 | $37.001400 | -98% | Dec 2023 |
|
Who sold out of Eiger Biopharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Simplify Asset Management | Sep 2023 | 2.7M | $824k |
| GSA Capital Partners | Sep 2023 | 356k | $109k |
| DRW Holdings | Sep 2023 | 120k | $37k |
| Sigma Planning | Sep 2023 | 42k | $13k |
| Two Sigma Investments | Sep 2023 | 18k | $5.5k |
| China Universal Asset Management | Sep 2023 | 1.1k | $0 |
| Sound Income Strategies | Dec 2023 | 400.00 | $90.000000 |
| Perkins Coie Trust | Dec 2023 | 178.00 | $38.999800 |